-
公开(公告)号:US20210386923A1
公开(公告)日:2021-12-16
申请号:US17412846
申请日:2021-08-26
Applicant: NxStage Medical, Inc.
Inventor: Jeffrey H. BURBANK , James M. BRUGGER , Dennis M. TREU , Mark T. WYETH
Abstract: A treatment device system includes a treatment machine for performing a therapy on a patient, the treatment machine including at least one fluid conveyor and a controller, the controller having a first memory, to cause the at least one fluid conveyor to produce a therapeutic fluid by mixing purified water and at least one concentrate. The system also includes and a water purifier in fluid communication with and providing the purified water to the treatment machine. A wired or wireless control line provides two way communication between the controller of the treatment machine and the internal central controller of the water purifier, wherein the controller of the treatment machine transmits data via the control line to the internal central controller of the water purifier for control of the water purifier, the data provided based on at least one of the operator inputs received via the user interface.
-
公开(公告)号:US20210205519A1
公开(公告)日:2021-07-08
申请号:US17212866
申请日:2021-03-25
Applicant: NxStage Medical, Inc.
Inventor: Jeffrey H. BURBANK , Dennis M. TREU , Goetz FRIEDERICHS , Brian C. GREEN , Christopher S. MCDOWELL , James M. BRUGGER
Abstract: A fluid treatment plant has a filter module including at least a first filter and a second filter connected in series and connectable to a supply of fluid. A pump is fluidly connected to the filter module and a controller with a fluid quality sensor is connected to detect a quality of the fluid between the first filter and the second filter. A filter module detector is connected to the controller configured to uniquely detect a filter module connected to the pump, and the controller is controls the pump responsively to a signal from the fluid quality sensor and the module detector. The controller is configured to continue pumping based on output of the quality sensor and/or based on output from the filter module detector.
-
公开(公告)号:US20210178041A1
公开(公告)日:2021-06-17
申请号:US17189879
申请日:2021-03-02
Applicant: NxStage Medical, Inc.
Inventor: Goetz FRIEDERICHS , Dennis M. TREU , Jeffrey H. BURBANK , Yuriy N. TATASHIN
Abstract: A method of automatically ensuring against chloramine contamination in purified product water includes supplying input water to the system and purifying the water to generate the purified product water. The purifying includes removing chlorine and chloramine contamination from the water using a carbon filter and supplying chlorine-depleted water to a deionization filter, and deionizing the chlorine-depleted water using said deionization filter. The product water is supplied to a sensor for continuous monitoring of the resistivity of the purified product water by the first sensor, and an alarm is generated indicating possible chloramine breakthrough when the resistivity of the product water falls below a predetermined resistivity level, which is selected to provide a reserve filter capacity before breakthrough would occur. The carbon filter is replaced at least responsively to the alarm to ensure excess capacity of said carbon filter sufficient to prevent chloramine breakthrough in said product water.
-
公开(公告)号:US20210060226A1
公开(公告)日:2021-03-04
申请号:US17097724
申请日:2020-11-13
Applicant: NxStage Medical, Inc.
Inventor: Jeffrey H. BURBANK , Dennis M. TREU , Daniel Joseph RUBERY, JR. , Scott W. NEWELL , James M. BRUGGER , William J. SCHNELL , William K. WEIGEL , Steven A. WHITE , Mark T. WYETH , Jerome JAMES , David DESOUZA , Joseph E. TURK, JR. , Garrett CASEY
Abstract: The disclosed subject matter relates to extracorporeal blood processing or other processing of fluids. Volumetric fluid balance, a required element of many such processes, may be achieved with multiple pumps or other proportioning or balancing devices which are to some extent independent of each other. This need may arise in treatments that involve multiple fluids. Safe and secure mechanisms to ensure fluid balance in such systems are described.
-
公开(公告)号:US20190240387A1
公开(公告)日:2019-08-08
申请号:US16381363
申请日:2019-04-11
Applicant: NxStage Medical, Inc.
Inventor: Jeffrey H. BURBANK , Dennis M. TREU , Daniel J. Rubery, JR. , Scott W. NEWELL , James M. BRUGGER , William J. SCHNELL , William K. WEIGEL , Steven A. WHITE , Mark T. WYETH , Jerome JAMES , David DESOUZA , Joseph E. Turk, JR. , Garrett CASEY
CPC classification number: A61M1/1605 , A61M1/14 , A61M1/1613 , A61M1/1615 , A61M1/1647 , A61M1/165 , A61M1/34 , A61M1/3403 , A61M1/341 , A61M1/3434 , A61M1/3437 , A61M1/3441 , A61M1/3444 , A61M1/3448 , A61M1/3607 , A61M1/3609 , A61M1/3635 , A61M2205/058 , A61M2205/15 , A61M2205/3331 , A61M2205/3334 , A61M2205/3341 , A61M2205/3351 , A61M2205/3355 , A61M2205/3365 , A61M2205/3368 , A61M2205/502 , A61M2205/702
Abstract: The disclosed subject matter relates to extracorporeal blood processing or other processing of fluids. Volumetric fluid balance, a required element of many such processes, may be achieved with multiple pumps or other proportioning or balancing devices which are to some extent independent of each other. This need may arise in treatments that involve multiple fluids. Safe and secure mechanisms to ensure fluid balance in such systems are described.
-
公开(公告)号:US20190231958A1
公开(公告)日:2019-08-01
申请号:US16381369
申请日:2019-04-11
Applicant: NxStage Medical, Inc.
Inventor: Jeffrey H. BURBANK , Dennis M. TREU , Daniel J. RUBERY, JR. , Scott W. NEWELL , James M. BRUGGER , William J. SCHNELL , William K. WEIGEL , Steven A. WHITE , Mark T. WYETH , Jerome JAMES , David DESOUZA , Joseph E. TURK, JR. , Garrett CASEY
CPC classification number: A61M1/1605 , A61M1/14 , A61M1/1613 , A61M1/1615 , A61M1/1647 , A61M1/165 , A61M1/34 , A61M1/3403 , A61M1/341 , A61M1/3434 , A61M1/3437 , A61M1/3441 , A61M1/3444 , A61M1/3448 , A61M1/3607 , A61M1/3609 , A61M1/3635 , A61M2205/058 , A61M2205/15 , A61M2205/3331 , A61M2205/3334 , A61M2205/3341 , A61M2205/3351 , A61M2205/3355 , A61M2205/3365 , A61M2205/3368 , A61M2205/502 , A61M2205/702
Abstract: The disclosed subject matter relates to extracorporeal blood processing or other processing of fluids. Volumetric fluid balance, a required element of many such processes, may be achieved with multiple pumps or other proportioning or balancing devices which are to some extent independent of each other. This need may arise in treatments that involve multiple fluids. Safe and secure mechanisms to ensure fluid balance in such systems are described.
-
公开(公告)号:US20180207342A1
公开(公告)日:2018-07-26
申请号:US15924425
申请日:2018-03-19
Applicant: NxStage Medical, Inc.
Inventor: Goetz FRIEDERICHS , Dennis M. TREU , Jeffrey H. BURBANK , Yuriy N. TATASHIN
IPC: A61M1/16 , C02F1/28 , C02F1/42 , C02F103/02 , C02F1/00 , C02F1/44 , C02F1/32 , C02F101/12
CPC classification number: A61M1/1656 , A61M1/1664 , A61M1/1666 , A61M1/1672 , C02F1/001 , C02F1/283 , C02F1/32 , C02F1/42 , C02F1/441 , C02F2001/427 , C02F2101/12 , C02F2103/026 , C02F2209/003 , C02F2209/02 , C02F2209/05 , C02F2209/29 , C02F2209/445
Abstract: A method of automatically ensuring against chloramine contamination in purified product water includes supplying input water to the system and purifying the water to generate the purified product water. The purifying includes removing chlorine and chloramine contamination from the water using a carbon filter and supplying chlorine-depleted water to a deionization filter, and deionizing the chlorine-depleted water using said deionization filter. The product water is supplied to a sensor for continuous monitoring of the resistivity of the purified product water by the first sensor, and an alarm is generated indicating possible chloramine breakthrough when the resistivity of the product water falls below a predetermined resistivity level, which is selected to provide a reserve filter capacity before breakthrough would occur. The carbon filter is replaced at least responsively to the alarm to ensure excess capacity of said carbon filter sufficient to prevent chloramine breakthrough in said product water.
-
公开(公告)号:US20170312419A1
公开(公告)日:2017-11-02
申请号:US15655091
申请日:2017-07-20
Applicant: NXSTAGE MEDICAL, INC.
Inventor: Jeffrey H. BURBANK , Dennis M. TREU , James M. BRUGGER , Daniel Joseph RUBERY, JR.
CPC classification number: A61M1/3656 , A61M1/367 , A61M2205/15 , G01M3/04 , Y10T137/5762
Abstract: Features for protecting against leaks in a fluid circuit are disclosed. In an embodiment, a first indicator of a leak is used to trigger confirmation by blood flow reversal and air detection in the blood circuit. A method for performing a blood treatment includes, at blood treatment machine, pumping blood to a patient through a first blood line. Further, at a controller of the blood treatment machine, a first signal is received, indicating a probability of a leak in the first blood line. Responsively to the first signal, the controller commands a leak verification operation and receives a second signal indicating whether a leak in the first blood line is verified. Further, a leak indicating signal is generated if the second signal indicates a leak is verified.
-
公开(公告)号:US20170182237A1
公开(公告)日:2017-06-29
申请号:US15400978
申请日:2017-01-07
Applicant: NxStage Medical, Inc.
Inventor: Jeffrey H. BURBANK , James M. BRUGGER , Dennis M. TREU , Mark T. WYETH
IPC: A61M1/28
CPC classification number: A61M1/28 , A61M1/1656 , A61M1/166 , A61M1/1664 , A61M1/1668 , A61M1/167 , A61M1/1672 , A61M1/1674 , A61M1/281 , A61M1/282 , A61M1/285 , A61M1/287 , A61M1/288 , A61M2025/0002 , A61M2205/12 , A61M2205/123 , A61M2205/128 , A61M2205/14 , A61M2205/18 , A61M2205/33 , A61M2205/3331 , A61M2205/3334 , A61M2205/3351 , A61M2205/3355 , A61M2205/52 , A61M2230/005
Abstract: An automated peritoneal dialysis system provides various features including prescription-driven dialysis fluid preparation, an integrated disposable fluid circuit, and sensor capabilities that allow accurate filing and draining control with high safety margins. Features include a peritoneal fluid circuit with a pressure sensor at either end and methods and devices for using the pressure signals. Other features and embodiments are disclosed.
-
公开(公告)号:US20220375592A1
公开(公告)日:2022-11-24
申请号:US17882073
申请日:2022-08-05
Applicant: NxStage Medical, Inc.
Inventor: Jeffrey H. BURBANK , Dennis M. TREU , James M. BRUGGER
IPC: G16H40/63 , A61M1/14 , A61M1/36 , A61B5/117 , A61B5/00 , G16H40/67 , G16H30/40 , G16Z99/00 , G05B1/01 , G05B9/02 , G08B21/22 , A61B5/01 , A61B5/08 , G08B21/18
Abstract: A medical treatment device is configured to be used during a treatment session at a first location and includes a medical treatment component configured to perform at least one of hemodialysis, hemofiltration, and peritoneal dialysis on a patient during the treatment session at the first location. The device also includes a monitoring system configured to receive data from one or more sensors connected to the monitoring system, and to confirm a presence of an authorized helper at the first location. A user interface permits an operator to control functions of the medical treatment component and the monitoring system is configured to perform the presence confirmation automatically and at the predefined time intervals during the treatment session. The monitoring system is also configured to generate an alarm and to cause the medical treatment component to go into a failsafe operational mode.
-
-
-
-
-
-
-
-
-